On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
On Mar. 24, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
On Mar. 23, 2020, Heat Biologics announced that it was collaborating with the University of Miami to develop…
On Mar. 23, 2020, LabCorpﾮ announced that it is exploring all options to prioritize COVID-19 testing for the…
On Mar. 23, 2020, Novan announced that it intends to explore the use of its proprietary Nitricil technology…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
On Mar. 20, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
On Mar. 20, 2020, Humanigen announced that the company was seeking to conduct a Phase III, randomized, controlled,…
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
On Mar. 19, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the company’s molecular…
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…